Xin-Yi Tian, Hong-Rui An, Guo-Xue Qi, Rui-Tao Wu, Fu Ma, Meng Zhang, Fang Chen, Xiang-Bin Xin
{"title":"ARMC5突变与双侧肾上腺大结节性增生和原发性醛固酮增多症的关系:1例报告。","authors":"Xin-Yi Tian, Hong-Rui An, Guo-Xue Qi, Rui-Tao Wu, Fu Ma, Meng Zhang, Fang Chen, Xiang-Bin Xin","doi":"10.5414/CN111653","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Mutations in the <i>ARMC5</i> gene are generally associated with bilateral macronodular adrenal hyperplasia (BMAH), whereas primary aldosteronism (PA) is most commonly linked to adrenal cortical adenomas (ACA). Recent studies have identified <i>ARMC5</i> mutations in certain PA cases; however, it remains unclear whether BMAH associated with <i>ARMC5</i> mutations can directly contribute to PA.</p><p><strong>Case description: </strong>A patient undergoing evaluation for secondary hypertension was diagnosed with BMAH, an elevated aldosterone/renin ratio (ARR) suggestive of PA, and subclinical Cushing's syndrome (SCS). Adrenal venous sampling (AVS) indicated left-sided dominance. Genetic testing confirmed <i>ARMC5</i> mutations in the patient and their son. A subsequent partial left adrenalectomy identified a golden-yellow adrenal tumor, which pathological analysis classified as an ACA. However, given the overlapping histological and clinical features of bilateral multifocal ACA and BMAH, the histological findings were reconsidered. The association of <i>ARMC5</i> mutations with BMAH rather than ACA, in conjunction with imaging findings and a history of meningioma, supports a diagnosis of <i>ARMC5</i> mutation-associated BMAH.</p><p><strong>Conclusion: </strong>This case suggests that <i>ARMC5</i> mutation-associated BMAH may contribute to the development of PA, expanding the understanding of the genetic underpinnings of PA in BMAH.</p>","PeriodicalId":10396,"journal":{"name":"Clinical nephrology","volume":" ","pages":"78-86"},"PeriodicalIF":1.1000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Association between ARMC5 mutation with bilateral macronodular adrenal hyperplasia and primary aldosteronism: A case report.\",\"authors\":\"Xin-Yi Tian, Hong-Rui An, Guo-Xue Qi, Rui-Tao Wu, Fu Ma, Meng Zhang, Fang Chen, Xiang-Bin Xin\",\"doi\":\"10.5414/CN111653\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Mutations in the <i>ARMC5</i> gene are generally associated with bilateral macronodular adrenal hyperplasia (BMAH), whereas primary aldosteronism (PA) is most commonly linked to adrenal cortical adenomas (ACA). Recent studies have identified <i>ARMC5</i> mutations in certain PA cases; however, it remains unclear whether BMAH associated with <i>ARMC5</i> mutations can directly contribute to PA.</p><p><strong>Case description: </strong>A patient undergoing evaluation for secondary hypertension was diagnosed with BMAH, an elevated aldosterone/renin ratio (ARR) suggestive of PA, and subclinical Cushing's syndrome (SCS). Adrenal venous sampling (AVS) indicated left-sided dominance. Genetic testing confirmed <i>ARMC5</i> mutations in the patient and their son. A subsequent partial left adrenalectomy identified a golden-yellow adrenal tumor, which pathological analysis classified as an ACA. However, given the overlapping histological and clinical features of bilateral multifocal ACA and BMAH, the histological findings were reconsidered. The association of <i>ARMC5</i> mutations with BMAH rather than ACA, in conjunction with imaging findings and a history of meningioma, supports a diagnosis of <i>ARMC5</i> mutation-associated BMAH.</p><p><strong>Conclusion: </strong>This case suggests that <i>ARMC5</i> mutation-associated BMAH may contribute to the development of PA, expanding the understanding of the genetic underpinnings of PA in BMAH.</p>\",\"PeriodicalId\":10396,\"journal\":{\"name\":\"Clinical nephrology\",\"volume\":\" \",\"pages\":\"78-86\"},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical nephrology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.5414/CN111653\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5414/CN111653","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
Association between ARMC5 mutation with bilateral macronodular adrenal hyperplasia and primary aldosteronism: A case report.
Background: Mutations in the ARMC5 gene are generally associated with bilateral macronodular adrenal hyperplasia (BMAH), whereas primary aldosteronism (PA) is most commonly linked to adrenal cortical adenomas (ACA). Recent studies have identified ARMC5 mutations in certain PA cases; however, it remains unclear whether BMAH associated with ARMC5 mutations can directly contribute to PA.
Case description: A patient undergoing evaluation for secondary hypertension was diagnosed with BMAH, an elevated aldosterone/renin ratio (ARR) suggestive of PA, and subclinical Cushing's syndrome (SCS). Adrenal venous sampling (AVS) indicated left-sided dominance. Genetic testing confirmed ARMC5 mutations in the patient and their son. A subsequent partial left adrenalectomy identified a golden-yellow adrenal tumor, which pathological analysis classified as an ACA. However, given the overlapping histological and clinical features of bilateral multifocal ACA and BMAH, the histological findings were reconsidered. The association of ARMC5 mutations with BMAH rather than ACA, in conjunction with imaging findings and a history of meningioma, supports a diagnosis of ARMC5 mutation-associated BMAH.
Conclusion: This case suggests that ARMC5 mutation-associated BMAH may contribute to the development of PA, expanding the understanding of the genetic underpinnings of PA in BMAH.
期刊介绍:
Clinical Nephrology appears monthly and publishes manuscripts containing original material with emphasis on the following topics: prophylaxis, pathophysiology, immunology, diagnosis, therapy, experimental approaches and dialysis and transplantation.